KRN7000 analog 1 stimulates a strong Th1-biased immune response by inducing interferon-gamma (IFN-gamma) and reducing interleukin-4 (IL-4). This compound shows potential as an antitumor agent and vaccine adjuvant.
Formula:
C47H76FNO9S
Target:
Interleukin|||IFNAR
* VAT and and shipping costs not included. Errors and price changes excepted
